Kevin Sheng-Kai

575 total citations
22 papers, 266 citations indexed

About

Kevin Sheng-Kai is a scholar working on Pharmacology, Dermatology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Kevin Sheng-Kai has authored 22 papers receiving a total of 266 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 5 papers in Dermatology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Kevin Sheng-Kai's work include Drug-Induced Adverse Reactions (5 papers), Corneal Surgery and Treatments (3 papers) and Contact Dermatitis and Allergies (2 papers). Kevin Sheng-Kai is often cited by papers focused on Drug-Induced Adverse Reactions (5 papers), Corneal Surgery and Treatments (3 papers) and Contact Dermatitis and Allergies (2 papers). Kevin Sheng-Kai collaborates with scholars based in Taiwan, United States and China. Kevin Sheng-Kai's co-authors include Yi‐Jen Hsueh, David Hui‐Kang, Yiwen Chen, Li‐Tzu Wang, Hung‐Chi Chen, Jui‐Yang Lai, Jan‐Kan Chen, Edward Krupat, Hui‐Chin Chang and Chyong‐Huey Lai and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Ophthalmology.

In The Last Decade

Kevin Sheng-Kai

20 papers receiving 264 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin Sheng-Kai Taiwan 12 48 46 46 39 38 22 266
Hyung‐Joon Ahn South Korea 9 55 1.1× 16 0.3× 63 1.4× 14 0.4× 50 1.3× 34 309
Asghar Ebadifar Iran 11 33 0.7× 72 1.6× 17 0.4× 13 0.3× 56 1.5× 45 349
Manoela Domingues Martins Brazil 10 38 0.8× 59 1.3× 24 0.5× 4 0.1× 27 0.7× 18 294
Daniela Martins‐Mendes Portugal 9 83 1.7× 14 0.3× 38 0.8× 6 0.2× 78 2.1× 19 605
Keith Godfrey Thailand 14 29 0.6× 162 3.5× 16 0.3× 10 0.3× 102 2.7× 44 677
Fabrício Mesquita Tuji Brazil 11 95 2.0× 29 0.6× 24 0.5× 7 0.2× 60 1.6× 36 394
Takaaki Oda Japan 12 85 1.8× 64 1.4× 25 0.5× 36 0.9× 88 2.3× 25 336
Roy S. Rogers United States 9 112 2.3× 11 0.2× 74 1.6× 23 0.6× 37 1.0× 12 392
Haşmet Yazıcı Türkiye 11 40 0.8× 7 0.2× 50 1.1× 6 0.2× 93 2.4× 40 308
Pascal Coquerelle France 10 145 3.0× 17 0.4× 70 1.5× 25 0.6× 56 1.5× 21 367

Countries citing papers authored by Kevin Sheng-Kai

Since Specialization
Citations

This map shows the geographic impact of Kevin Sheng-Kai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Sheng-Kai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Sheng-Kai more than expected).

Fields of papers citing papers by Kevin Sheng-Kai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Sheng-Kai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Sheng-Kai. The network helps show where Kevin Sheng-Kai may publish in the future.

Co-authorship network of co-authors of Kevin Sheng-Kai

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Sheng-Kai. A scholar is included among the top collaborators of Kevin Sheng-Kai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Sheng-Kai. Kevin Sheng-Kai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sheng-Kai, Kevin, et al.. (2025). Dupilumab and lymphoma risk among patients with asthma: a population-based cohort study. European Respiratory Journal. 66(3). 2500139–2500139. 4 indexed citations
2.
Li, Yuan, et al.. (2025). Mesenchymal stem cell therapy as a game-changer in liver diseases: review of current clinical trials. Stem Cell Research & Therapy. 16(1). 3–3. 8 indexed citations
3.
Freitag, Suzanne K., et al.. (2025). Long-term Cardiovascular, Renal, and Safety Outcomes of Teprotumumab versus Systemic Glucocorticoids in Thyroid Eye Disease. Ophthalmology. 132(10). 1142–1151. 1 indexed citations
4.
Growdon, Amanda S., et al.. (2024). Increasing Incidence of Serious Head and Neck Infections among Children in the United States, 2018-2023. The Journal of Pediatrics. 279. 114458–114458.
5.
Wang, Chuang‐Wei, Tsung‐Ying Tsai, Shin‐Yi Chen, et al.. (2024). Post hoc Analysis of Role of Etanercept in Ocular Sequelae of Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis. Ophthalmology. 131(7). 864–866. 4 indexed citations
6.
Sheng-Kai, Kevin, et al.. (2023). Ocular surface complications following biological therapy for cancer. SHILAP Revista de lepidopterología. 5. 1137637–1137637. 9 indexed citations
7.
Chen, Chao-Sheng, et al.. (2023). A novel method for synthesis of carbon dots and their applications in reactive oxygen species (ROS) and glucose detections. RSC Advances. 13(40). 28250–28261. 6 indexed citations
8.
Chen, Yiwen, et al.. (2022). Age-dependent oral manifestations of neurofibromatosis type 1: a case–control study. Orphanet Journal of Rare Diseases. 17(1). 93–93. 12 indexed citations
9.
Sheng-Kai, Kevin, et al.. (2022). Severity of periodontitis and salivary interleukin-1β are associated with psoriasis involvement. Journal of the Formosan Medical Association. 121(10). 1908–1916. 16 indexed citations
10.
Sheng-Kai, Kevin, Yi‐Jen Hsueh, Shin‐Yi Chen, et al.. (2021). Human leucocyte antigen association of patients with Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications in Han Chinese. British Journal of Ophthalmology. 106(5). 610–615. 22 indexed citations
11.
12.
Hui‐Kang, David, Yi‐Jen Hsueh, Kevin Sheng-Kai, et al.. (2021). Long-term survival of cultivated oral mucosal epithelial cells in human cornea: generating cell sheets using an animal product-free culture protocol. Stem Cell Research & Therapy. 12(1). 524–524. 15 indexed citations
13.
14.
Wang, Chen‐Ying, Bor‐Shiunn Lee, Kevin Sheng-Kai, et al.. (2021). Er:YAG laser irradiation enhances bacterial and lipopolysaccharide clearance and human gingival fibroblast adhesion on titanium discs. Scientific Reports. 11(1). 23954–23954. 12 indexed citations
15.
Sheng-Kai, Kevin, Hajirah N. Saeed, James Chodosh, et al.. (2021). Ocular manifestations of anti-neoplastic immune checkpoint inhibitor-associated Stevens-Johnson syndrome/toxic epidermal necrolysis in cancer patients. The Ocular Surface. 22. 47–50. 26 indexed citations
16.
Sheng-Kai, Kevin, Hui‐Chin Chang, & Edward Krupat. (2021). Teaching evidence-based medicine with electronic databases for preclinical education. AJP Advances in Physiology Education. 45(4). 849–855. 15 indexed citations
17.
Sheng-Kai, Kevin. (2020). Integrating travel history via big data analytics under universal healthcare framework for disease control and prevention in the COVID-19 pandemic. Journal of Clinical Epidemiology. 130. 147–148. 14 indexed citations
18.
19.
Hsueh, Yi‐Jen, Shiang‐Fu Huang, Jui‐Yang Lai, et al.. (2016). Preservation of epithelial progenitor cells from collagenase-digested oral mucosa during ex vivo cultivation. Scientific Reports. 6(1). 36266–36266. 21 indexed citations
20.
Hui‐Kang, David, Hung‐Chi Chen, Kevin Sheng-Kai, et al.. (2015). Preservation of human limbal epithelial progenitor cells on carbodiimide cross-linked amniotic membrane via integrin-linked kinase-mediated Wnt activation. Acta Biomaterialia. 31. 144–155. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hyung‐Joon Ahn Breakdown of academic impact, for papers by Asghar Ebadifar Breakdown of academic impact, for papers by Manoela Domingues Martins Breakdown of academic impact, for papers by Daniela Martins‐Mendes Breakdown of academic impact, for papers by Keith Godfrey Breakdown of academic impact, for papers by Fabrício Mesquita Tuji Breakdown of academic impact, for papers by Takaaki Oda Breakdown of academic impact, for papers by Roy S. Rogers Breakdown of academic impact, for papers by Haşmet Yazıcı Breakdown of academic impact, for papers by Pascal Coquerelle
Rankless by CCL
2026